First Trimester Down Syndrome Screening: Public Health Implications

This publication has 17 references indexed in Scilit:

• First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)
  American Journal of Obstetrics and Gynecology, 2004
• Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities
  American Journal of Obstetrics and Gynecology, 2004
• An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years
  American Journal of Obstetrics and Gynecology, 2004
• First- and second-trimester evaluation of risk (faster) trial: principal results of the NICHD multicenter down syndrome screening study
  American Journal of Obstetrics and Gynecology, 2003
• Use of overall population, center-specific, and sonographer-specific nuchal translucency medians in down syndrome screening: which is best? (Results from the faster trial)
  American Journal of Obstetrics and Gynecology, 2003
• First-Trimester Sonographic Screening for Down Syndrome*1
  Published by Wolters Kluwer Health ,2003
• Executive summary
  Journal of Medical Screening, 2003
• Increased fetal nuchal translucency at 11–14 weeks
  Prenatal Diagnosis, 2002
• First-trimester screening for aneuploidy: Research or standard of care?
  American Journal of Obstetrics and Gynecology, 2000
• ESTABLISHMENT AND APPLICATION OF A NORMAL RANGE FOR NUCHAL TRANSLUCENCY ACROSS THE FIRST TRIMESTER
  Prenatal Diagnosis, 1996